314 related articles for article (PubMed ID: 17761156)
1. Modulation of CLA, IL-12R, CD40L, and IL-2Ralpha expression and inhibition of IL-12- and IL-23-induced cytokine secretion by CNTO 1275.
Reddy M; Davis C; Wong J; Marsters P; Pendley C; Prabhakar U
Cell Immunol; 2007 May; 247(1):1-11. PubMed ID: 17761156
[TBL] [Abstract][Full Text] [Related]
2. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous lymphocyte antigen expression on activated lymphocytes and its association with IL-12R (beta1 and beta2), IL-2Ralpha, and CXCR3.
Reddy M; Davis C; Wong J; Prabhakar U
Cell Immunol; 2005; 236(1-2):131-9. PubMed ID: 16165116
[TBL] [Abstract][Full Text] [Related]
4. IFN-beta inhibits human Th17 cell differentiation.
Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
[TBL] [Abstract][Full Text] [Related]
5. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
6. The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer.
Mattner F; Fischer S; Guckes S; Jin S; Kaulen H; Schmitt E; Rüde E; Germann T
Eur J Immunol; 1993 Sep; 23(9):2202-8. PubMed ID: 8103745
[TBL] [Abstract][Full Text] [Related]
7. Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma.
Antúnez C; Torres MJ; Mayorga C; Corzo JL; Jurado A; Santamaría-Babi LF; Vera A; Blanca M
Pediatr Allergy Immunol; 2006 May; 17(3):166-74. PubMed ID: 16672002
[TBL] [Abstract][Full Text] [Related]
8. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production.
McDyer JF; Li Z; John S; Yu X; Wu CY; Ragheb JA
J Immunol; 2002 Sep; 169(5):2736-46. PubMed ID: 12193748
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 12-augmented T cell proliferation of peripheral blood mononuclear cells from HIV-seropositive individuals is associated with interleukin 12 receptor beta 2 upregulation.
Jones ML; Young JM; Huang QR; Puls RL; Webber CA; Benson EM
AIDS Res Hum Retroviruses; 2003 Apr; 19(4):283-92. PubMed ID: 12804004
[TBL] [Abstract][Full Text] [Related]
10. T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines.
Tada Y; O-Wang J; Yu L; Shimozato O; Wang YQ; Takiguchi Y; Tatsumi K; Kuriyama T; Takenaga K; Sakiyama S; Tagawa M
Cancer Gene Ther; 2003 Jun; 10(6):451-6. PubMed ID: 12768190
[TBL] [Abstract][Full Text] [Related]
11. An early imbalance of interleukin 12 influences the adjuvant effect of mannoproteins of Cryptococcus neoformans.
Pietrella D; Lupo P; Bistoni F; Vecchiarelli A
Cell Microbiol; 2004 Sep; 6(9):883-91. PubMed ID: 15272868
[TBL] [Abstract][Full Text] [Related]
12. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
[TBL] [Abstract][Full Text] [Related]
13. Human recombinant interferon-beta influences T helper subset differentiation by regulating cytokine secretion pattern and expression of homing receptors.
McRae BL; Picker LJ; van Seventer GA
Eur J Immunol; 1997 Oct; 27(10):2650-6. PubMed ID: 9368622
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma and interleukin-4 regulate T cell interleukin-12 responsiveness through the differential modulation of high-affinity interleukin-12 receptor expression.
Gollob JA; Kawasaki H; Ritz J
Eur J Immunol; 1997 Mar; 27(3):647-52. PubMed ID: 9079804
[TBL] [Abstract][Full Text] [Related]
15. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
16. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
17. Th1-mediated intestinal inflammation in Crohn's disease may be induced by activation of lamina propria lymphocytes through synergistic stimulation of interleukin-12 and interleukin-18 without T cell receptor engagement.
Okazawa A; Kanai T; Watanabe M; Yamazaki M; Inoue N; Ikeda M; Kurimoto M; Ishii H; Hibi T
Am J Gastroenterol; 2002 Dec; 97(12):3108-17. PubMed ID: 12492197
[TBL] [Abstract][Full Text] [Related]
18. IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human.
Vanden Eijnden S; Goriely S; De Wit D; Willems F; Goldman M
Eur J Immunol; 2005 Feb; 35(2):469-75. PubMed ID: 15682457
[TBL] [Abstract][Full Text] [Related]
19. Biological function and distribution of human interleukin-12 receptor beta chain.
Wu CY; Warrier RR; Carvajal DM; Chua AO; Minetti LJ; Chizzonite R; Mongini PK; Stern AS; Gubler U; Presky DH; Gately MK
Eur J Immunol; 1996 Feb; 26(2):345-50. PubMed ID: 8617302
[TBL] [Abstract][Full Text] [Related]
20. Regulation of interleukin-12 receptor beta1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells.
Wu C; Warrier RR; Wang X; Presky DH; Gately MK
Eur J Immunol; 1997 Jan; 27(1):147-54. PubMed ID: 9022011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
